Verastem Inc (VSTM)
4.12
-8.06
(-66.17%)
USD |
NASDAQ |
May 24, 16:00
4.20
+0.08
(+1.94%)
After-Hours: 20:00
Verastem Free Cash Flow: -94.50M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -94.50M |
December 31, 2023 | -86.46M |
September 30, 2023 | -73.40M |
June 30, 2023 | -71.89M |
March 31, 2023 | -64.68M |
December 31, 2022 | -63.67M |
September 30, 2022 | -56.99M |
June 30, 2022 | -52.74M |
March 31, 2022 | -53.46M |
December 31, 2021 | -53.70M |
September 30, 2021 | -65.47M |
June 30, 2021 | -9.90M |
March 31, 2021 | -19.05M |
December 31, 2020 | -33.54M |
September 30, 2020 | -49.06M |
June 30, 2020 | -121.65M |
March 31, 2020 | -133.75M |
December 31, 2019 | -138.52M |
September 30, 2019 | -142.76M |
June 30, 2019 | -138.03M |
March 31, 2019 | -114.25M |
December 31, 2018 | -98.02M |
September 30, 2018 | -76.90M |
June 30, 2018 | -65.62M |
March 31, 2018 | -69.21M |
Date | Value |
---|---|
December 31, 2017 | -57.31M |
September 30, 2017 | -42.94M |
June 30, 2017 | -37.14M |
March 31, 2017 | -29.35M |
December 31, 2016 | -29.52M |
September 30, 2016 | -33.78M |
June 30, 2016 | -39.34M |
March 31, 2016 | -44.67M |
December 31, 2015 | -45.77M |
September 30, 2015 | -45.78M |
June 30, 2015 | -44.87M |
March 31, 2015 | -41.97M |
December 31, 2014 | -39.33M |
September 30, 2014 | -35.67M |
June 30, 2014 | -32.08M |
March 31, 2014 | -29.31M |
December 31, 2013 | -26.36M |
September 30, 2013 | -25.71M |
June 30, 2013 | -25.49M |
March 31, 2013 | -24.22M |
December 31, 2012 | -22.91M |
September 30, 2012 | -21.10M |
June 30, 2012 | -18.85M |
March 31, 2012 | -14.32M |
December 31, 2011 | -9.372M |
Free Cash Flow Range, Past 5 Years
-142.76M
Minimum
Sep 2019
-9.90M
Maximum
Jun 2021
-76.16M
Average
-65.07M
Median
Free Cash Flow Benchmarks
Johnson & Johnson | 18.23B |
Geron Corp | -184.70M |
Altimmune Inc | -72.76M |
Oragenics Inc | -8.246M |
Actinium Pharmaceuticals Inc | -39.72M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -28.31M |
Cash from Investing (Quarterly) | 30.98M |
Cash from Financing (Quarterly) | 0.846M |
Free Cash Flow Per Share (Quarterly) | -1.056 |
Free Cash Flow Yield | -93.42% |